Novartis candidate for Sjögren’s disease presents positive results - Pharmafile

Novartis candidate for Sjögren’s disease presents positive results - Pharmafile

Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 – evaluating ianalumab in adults with active Sjögren’s disease. Both trials met their primary endpoint, showing statistically significant improvements in systemic disease activity compared with placebo, measured by the EULAR Sjögren’s syndrome disease activity index. Sjögren’s disease is a chronic […] The post Novartis candidate for Sjögren’s dise…